Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|June 6, 2021
Optimization of physicochemical properties of pyridone-based EP3 receptor antagonistsXuqing Zhang, Bin Zhu, Lili Guo, et al.
ACS Medicinal Chemistry Letters|March 19, 2021
Discovery of a Novel Series of Pyridone-Based EP3 Antagonists for the Treatment of Type 2 DiabetesXuqing Zhang, Bin Zhu, Lili Guo, et al.
JAMA Network Open|June 30, 2025
Clinical Outcomes of Perioperative Immunotherapy in Resectable Non-Small Cell Lung CancerAakash Desai, Karen Schwed, Laurynas Kalesinskas, et al.
Diabetes, Obesity & Metabolism|January 19, 2021
Amino acids are sensitive glucagon receptor-specific biomarkers for glucagon-like peptide-1 receptor/glucagon receptor dual agonistsWenyu Li, Thomas Kirchner, George Ho, et al.
Bioorganic & Medicinal Chemistry Letters|October 25, 2013
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable Stearoyl-CoA desaturase-1 (SCD1) inhibitors. Part 1: urea-based analogsShyh-Ming Yang, Yuting Tang, Rui Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|January 11, 2014
4-Bicyclic heteroaryl-piperidine derivatives as potent, orally bioavailable stearoyl-CoA desaturase-1 (SCD1) inhibitors: part 2. Pyridazine-based analogsShyh-Ming Yang, Yuting Tang, Thomas Rano, et al.
Molecular Metabolism|August 8, 2022
The mitochondrial fission protein Drp1 in liver is required to mitigate NASH and prevents the activation of the mitochondrial ISRJanos Steffen, Jennifer Ngo, Sheng-Ping Wang, et al.
Frontiers in Pharmacology|October 2, 2023
Approach to machine learning for extraction of real-world data variables from electronic health recordsBlythe Adamson, Michael Waskom, Auriane Blarre, et al.
Pageof 4